HK Stock MarketDetailed Quotes
03347 TIGERMED
- 27.350
- -0.050-0.18%
Not Open Jul 16 16:08 CST
23.66BMarket Cap12.67P/E (TTM)
27.800High27.100Low316.20KVolume27.300Open27.400Pre Close8.67MTurnover0.26%Turnover Ratio10.58P/E (Static)864.95MShares51.92652wk High1.01P/B3.37BFloat Cap21.47652wk Low0.62Dividend TTM123.12MShs Float197.719Historical High0.624Dividend LFY2.56%Amplitude21.476Historical Low27.427Avg Price100Lot Size2.28%Div YieldTTM2.28%Div Yield LFY
TIGERMED Key Stats
All
YOY
| (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -4.04%2.49B | ---- | ---- | ---- | -29.67%2.59B | ---- | ---- | ---- | 66.17%3.69B |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -0.90%-230.48M | ---- | ---- | ---- | 11.82%-228.43M | ---- | ---- | ---- | -127.05%-259.05M |
| Dividend (income)- adjustment | ---- | -528.22%-33.06M | ---- | ---- | ---- | 53.69%-5.26M | ---- | ---- | ---- | -559.99%-11.37M |
| Attributable subsidiary (profit) loss | ---- | -164.52%-105.18M | ---- | ---- | ---- | -177.13%-39.76M | ---- | ---- | ---- | -509.01%-14.35M |
| Impairment and provisions: | --0 | 177.10%68.1M | --0 | --0 | --0 | 0.61%24.58M | --0 | --0 | --0 | 342.44%24.43M |
| -Impairmen of inventory (reversal) | ---- | --3.17M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Impairment of goodwill | ---- | --29.16M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other impairments and provisions | ---- | 45.55%35.77M | ---- | ---- | ---- | 0.61%24.58M | ---- | ---- | ---- | 342.44%24.43M |
| Revaluation surplus: | --0 | 36.33%-349.17M | --0 | --0 | --0 | 69.55%-548.39M | --0 | --0 | --0 | -58.28%-1.8B |
| -Other fair value changes | ---- | 36.33%-349.17M | ---- | ---- | ---- | 69.55%-548.39M | ---- | ---- | ---- | -58.28%-1.8B |
| Asset sale loss (gain): | --0 | -286.89%-200.42M | --0 | --0 | --0 | 82.00%-51.8M | --0 | --0 | --0 | -1.81%-287.8M |
| -Available for sale investment sale loss (gain) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 2.56%-114.87M |
| -Loss (gain) from sale of subsidiary company | ---- | 96.94%-1.66M | ---- | ---- | ---- | 68.79%-54.14M | ---- | ---- | ---- | -4.69%-173.47M |
| -Loss (gain) on sale of property, machinery and equipment | ---- | 116.09%188K | ---- | ---- | ---- | -83.62%87K | ---- | ---- | ---- | -40.07%531K |
| -Loss (gain) from selling other assets | ---- | -8,966.04%-198.95M | ---- | ---- | ---- | --2.24M | ---- | ---- | ---- | ---- |
| Depreciation and amortization: | --0 | 19.02%339.02M | --0 | --0 | --0 | 44.77%284.84M | --0 | --0 | --0 | 30.95%196.76M |
| -Depreciation | ---- | 20.52%265.77M | ---- | ---- | ---- | 40.97%220.53M | ---- | ---- | ---- | 26.87%156.44M |
| -Amortization of intangible assets | ---- | 13.90%73.25M | ---- | ---- | ---- | 59.51%64.31M | ---- | ---- | ---- | 49.64%40.32M |
| Financial expense | ---- | 44.14%119.9M | ---- | ---- | ---- | 233.92%83.18M | ---- | ---- | ---- | -50.94%24.91M |
| Special items | ---- | -70.08%16.31M | ---- | ---- | ---- | -40.93%54.51M | ---- | ---- | ---- | 129.65%92.29M |
| Operating profit before the change of operating capital | --0 | -2.45%2.12B | --0 | --0 | --0 | 31.09%2.17B | --0 | --0 | --0 | 56.14%1.65B |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | 103.98%636K | ---- | ---- | ---- | -1,061.79%-15.96M | ---- | ---- | ---- | 60.91%-1.37M |
| Accounts receivable (increase)decrease | ---- | -65.22%-251.78M | ---- | ---- | ---- | 63.37%-152.39M | ---- | ---- | ---- | -567.08%-415.98M |
| Accounts payable increase (decrease) | ---- | 23.79%96.74M | ---- | ---- | ---- | -63.59%78.15M | ---- | ---- | ---- | 648.70%214.65M |
| Cash from business operations | --0 | -14.44%1.31B | --0 | --0 | --0 | 17.33%1.54B | --0 | --0 | --0 | 26.45%1.31B |
| Other taxs | ---- | 4.83%-382.63M | ---- | ---- | ---- | -175.31%-402.04M | ---- | ---- | ---- | -2.37%-146.03M |
| Special items of business | ---- | -19.22%-646.88M | ---- | ---- | ---- | -280.37%-542.59M | ---- | ---- | ---- | -1,207.08%-142.65M |
| Net cash from operations | 405.83%144.2M | -17.84%931.29M | -18.51%672.64M | 2.66%252.5M | -90.59%28.51M | -2.51%1.13B | 13.31%825.39M | -33.22%245.95M | 27.16%303.08M | 30.30%1.16B |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | ---- | -2.19%220.13M | ---- | 8.86%122.86M | ---- | -14.84%225.04M | ---- | -3.39%112.86M | ---- | 145.07%264.25M |
| Dividend received - investment | ---- | 792.04%46.95M | ---- | 8,882.64%10.87M | ---- | -53.69%5.26M | ---- | -97.70%121K | ---- | 559.99%11.37M |
| Loan receivable (increase) decrease | ---- | ---- | ---- | ---- | ---- | --53K | ---- | ---- | ---- | ---- |
| Decrease in deposits (increase) | ---- | -46.93%50.21M | ---- | -124.07%-232K | ---- | 582.22%94.62M | ---- | 196.40%964K | ---- | 84.40%-19.62M |
| Sale of fixed assets | 3,452.22%241.79K | 2.82%2.08M | 8,239.48%4.8M | 2,222.93%4.76M | 226.37%6.81K | 40.89%2.02M | -83.56%57.52K | 11.41%205K | 202.83%2.09K | 106.48%1.43M |
| Purchase of fixed assets | -33.38%-111.54M | 33.88%-304.89M | 34.09%-212.95M | -3.66%-153.29M | -33.77%-83.63M | -31.87%-461.1M | -20.07%-323.11M | 6.29%-147.87M | 52.55%-62.52M | -135.52%-349.67M |
| Purchase of intangible assets | ---- | 81.13%-10.59M | ---- | -303.02%-16.81M | ---- | -472.53%-56.13M | ---- | -81.51%-4.17M | ---- | -9.97%-9.8M |
| Sale of subsidiaries | ---- | -95.87%3.08M | ---- | ---- | ---- | -41.55%74.44M | ---- | 6.94%65M | ---- | 209.47%127.36M |
| Acquisition of subsidiaries | ---- | 20.04%-1.53B | 49.24%-344.2M | 57.62%-532.25M | ---- | -104.78%-1.91B | -3,495.20%-678.09M | -3,973.04%-1.26B | ---476.28M | -371.91%-934.62M |
| Recovery of cash from investments | -32.76%152.16M | 220.81%1.12B | 87.69%655.79M | 49.62%383.39M | 60.23%226.29M | -64.62%349.49M | -63.95%349.4M | -68.06%256.24M | -39.50%141.23M | -1.39%987.85M |
| Cash on investment | 76.21%-170.5M | -3.14%-912.95M | 6.28%-1.74B | 25.16%-405.56M | 27.84%-716.67M | 65.96%-885.18M | 38.33%-1.85B | 64.81%-541.91M | -16.82%-993.16M | 10.48%-2.6B |
| Other items in the investment business | -62.51%9.93M | ---- | -57.19%39.99M | ---- | -72.18%26.48M | ---- | 54.51%93.4M | ---- | 5,237.98%95.19M | ---- |
| Net cash from investment operations | 78.13%-119.72M | 48.74%-1.32B | 33.94%-1.59B | 61.29%-586.25M | 57.74%-547.51M | -1.74%-2.57B | -6.60%-2.41B | -102.77%-1.51B | -73.51%-1.3B | -13.01%-2.52B |
| Net cash before financing | 104.72%24.49M | 73.20%-383.79M | 41.97%-919.86M | 73.69%-333.75M | 47.71%-519M | -5.37%-1.43B | -3.41%-1.59B | -235.07%-1.27B | -95.24%-992.46M | -1.49%-1.36B |
| Cash flow from financing activities | ||||||||||
| New borrowing | -18.98%373.01M | -7.00%3.2B | 7.13%2.81B | -16.80%1.46B | -40.19%460.4M | 599.02%3.44B | 773.46%2.62B | --1.75B | --769.74M | -58.70%492.32M |
| Refund | 51.28%-82.9M | -37.18%-2.52B | -92.20%-1.85B | -99.30%-896.84M | 14.92%-170.16M | ---1.83B | ---960M | ---450M | ---200M | ---- |
| Issuing shares | ---- | -59.95%9.5M | ---- | 443.44%3.89M | ---- | 25.63%23.72M | ---- | -96.40%716K | ---- | -99.83%18.88M |
| Interest paid - financing | ---- | -67.77%-124.93M | ---- | -249.24%-66.1M | ---- | -196.71%-74.46M | ---- | -138.30%-18.93M | ---- | 50.58%-25.1M |
| Dividends paid - financing | 28.18%-30.26M | -28.41%-568.67M | -22.98%-570.88M | 96.73%-14.5M | -594.33%-42.14M | -55.41%-442.87M | -63.88%-464.21M | -58.62%-443.1M | -46.41%-6.07M | -20.07%-284.97M |
| Absorb investment income | -74.16%21.3M | -101.60%-5.05M | -26.14%246.02M | 6.50%240.06M | -65.99%82.42M | 799.29%315.4M | 26.41%333.08M | 557.70%225.4M | 169.43%242.35M | -77.36%35.07M |
| Issuance expenses and redemption of securities expenses | ---- | 92.99%-29.85M | ---- | 98.94%-4.23M | ---- | 17.23%-426.01M | ---- | ---398.72M | ---- | -15.49%-514.71M |
| Other items of the financing business | -882.69%-278.72M | 114.19%27.42M | 77.93%-162.31M | 10.82%-96.83M | 89.61%-28.36M | -267.45%-193.26M | -72.44%-735.48M | -236.75%-108.58M | -9,499.22%-272.94M | 262.33%115.41M |
| Net cash from financing operations | -99.20%2.42M | -100.96%-7.81M | -40.18%474.86M | 11.61%621.3M | -43.32%302.16M | 596.19%809.25M | 642.60%793.77M | 462.13%556.68M | 542.57%533.08M | -101.75%-163.09M |
| Effect of rate | 54.33%-5.07M | -67.35%8.79M | -77.19%22.21M | -16.30%25.88M | -538.43%-11.11M | 145.22%26.93M | 520.58%97.34M | 219.09%30.92M | -109.01%-1.74M | -25.44%-59.56M |
| Net Cash | 109.58%21.84M | 37.10%-391.59M | 39.09%-422.79M | 140.39%287.55M | 50.56%-227.95M | 59.09%-622.61M | 59.23%-694.15M | -33.74%-711.94M | -13.56%-461.11M | -119.02%-1.52B |
| Begining period cash | -4.92%7.4B | -7.11%7.78B | -7.11%7.78B | -7.11%7.78B | -7.11%7.78B | -15.88%8.38B | -15.88%8.38B | -15.88%8.38B | -15.88%8.38B | 396.28%9.96B |
| Cash at the end | -1.76%7.42B | -4.92%7.4B | -4.22%7.36B | 5.18%8.1B | -4.58%7.55B | -7.11%7.78B | -6.94%7.68B | -18.13%7.7B | -17.13%7.92B | -15.88%8.38B |
| Cash balance analysis | ||||||||||
| Cash and cash equivalent balance | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion |
| Auditor | -- | Lixin Certified Public Accountants (Special General Partnership), Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership), Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership), Hong Kong Lixin Dehao Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
HK
Overall
Symbol
Latest Price
%Chg